Vycor Medical OTC Stock Executives
| VYCO Stock | USD 0.07 0 1.47% |
Vycor Medical employs about 6 people. The company is managed by 3 executives with a total tenure of roughly 38 years, averaging almost 12.0 years of service per executive, having 2.0 employees per reported executive. Analysis of Vycor Medical's management performance can provide insight into the firm performance.
| Peter Zachariou CEO CEO and Director |
| Adrian Liddell Chairman Chairman, CFO, Principal Accounting Officer and Member of Audit Committee |
Vycor |
Vycor Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.2385) % which means that it has lost $0.2385 on every $100 spent on assets. This is way below average. Vycor Medical's management efficiency ratios could be used to measure how well Vycor Medical manages its routine affairs as well as how well it operates its assets and liabilities.Vycor Medical Workforce Comparison
Vycor Medical is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 101. Vycor Medical holds roughly 6.0 in number of employees claiming about 6% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.39) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31. Vycor Medical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Vycor Medical Price Series Summation is a cross summation of Vycor Medical price series and its benchmark/peer.
Vycor Medical Notable Stakeholders
A Vycor Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vycor Medical often face trade-offs trying to please all of them. Vycor Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vycor Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Peter Zachariou | CEO and Director | Profile | |
| Adrian Liddell | Chairman, CFO, Principal Accounting Officer and Member of Audit Committee | Profile | |
| David Cantor | Pres and Director | Profile |
About Vycor Medical Management Performance
The success or failure of an entity such as Vycor Medical often depends on how effective the management is. Vycor Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vycor management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vycor management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. Vycor Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 6 people.
The data published in Vycor Medical's official financial statements typically reflect Vycor Medical's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Vycor Medical's quantitative information. For example, before you start analyzing numbers published by Vycor accountants, it's essential to understand Vycor Medical's liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.
Vycor Medical Workforce Analysis
Traditionally, organizations such as Vycor Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vycor Medical within its industry.Vycor Medical Manpower Efficiency
Return on Vycor Medical Manpower
| Revenue Per Employee | 232.2K | |
| Revenue Per Executive | 464.3K | |
| Net Loss Per Employee | 72.6K | |
| Net Loss Per Executive | 145.2K |
Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.